• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Continuous Glucose Monitoring (CGM)

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

by Jasmine Pennic 09/16/2019 Leave a Comment

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More

Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring

by Fred Pennic 03/28/2019 Leave a Comment

Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring

Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More

DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution

by Jasmine Pennic 03/28/2019 Leave a Comment

diabetes management qualcomm medtronic diabetes

DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU

by Fred Pennic 03/20/2019 Leave a Comment

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU

OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU) has raised $20 million in Series E funding. The company plans to use the funding to support the commercialization of the company’s lead product, the OptiScanner 5000, in the United States. OptiScan will also use a portion of the funding to continue the expansion of the company’s OptiScanner platform to monitor additional analytes of interest for critically ill
Read More

Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens

by Fred Pennic 02/20/2019 Leave a Comment

Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens

Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More

Glooko Launches Integration with Novo Nordisk Insulin Pen

by Fred Pennic 02/18/2019 Leave a Comment

Glooko Launches Integration with Novo Nordisk Insulin Pen

Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report.  With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More

DexCom Integrates Continuous Glucose Monitoring Data with Validic Data Connectivity Platform

by Fred Pennic 10/17/2018 Leave a Comment

DexCom Integrates Continuous Glucose Monitoring Data with Validic Data Connectivity Platform

DexCom, Inc., a provider of continuous glucose monitoring (CGM) solutions, announced a partnership with data integration platform Validic. As part of the partnership, DexCom will integrate CGM data from Dexcom’s cloud API is integrated into the Validic’s connectivity platform to establish a multi-measure platform to stream in-home clinical data directly into clinical workflows and systems. This partnership is part of a larger effort to improve the interoperability of clinical systems and provide
Read More

Livongo Health and Abbott Partner to Offer Continuous Glucose Monitoring Insights

by Jasmine Pennic 09/05/2018 Leave a Comment

Livongo Health Raises $52.5M to Expand Diabetes Management to International Markets

Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More

Smart Meter’s Diabetes Care Solution Meets Newly Created Remote Monitoring CPT Code

by Fred Pennic 04/26/2018 Leave a Comment

Smart Meter's Diabetes Care Solution Meets Newly Created Remote Monitoring CPT Code

Smart Meter, an innovative diabetes management data, technology and solutions company, today announced that its iGlucose® Diabetes Care Solution meets the requirements for the newly created Remote Monitoring CPT Code, as defined by Centers of Medicare and Medicaid Services (CMS). The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, is providing clinicians with another tool for making connected health more available and more widely
Read More

FDA Approves Medtronic Smart Continuous Glucose Monitoring (CGM) System for Diabetes

by Fred Pennic 03/13/2018 Leave a Comment

diabetes management qualcomm medtronic diabetes

The FDA has just approved the Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart CGM system to help people with diabetes outsmart high and low glucose events. The system uses the power of real-time sensor glucose data, advanced algorithms and customizable, predictive alerts to notify people when sensor glucose levels are predicted to go too high or low – up to 60 minutes in advance.Understanding Continuous Glucose Monitoring (CGM)A CGM system provides
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |